We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BLGO market cap is 98.82M. The company's latest EPS is USD -0.0121 and P/E is -28.10.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.86M | 2.43M | 2.53M | 5.88M | 12.23M |
| Operating Income | -6.7M | -7.58M | -6.44M | -5.19M | -4.19M |
| Net Income | -10.69M | -8.43M | -7.08M | -4.47M | -3.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.62M | 4.94M | 3.02M | 4.86M | 8.21M |
| Total Liabilities | 5.8M | 5.18M | 2.09M | 2.85M | 4M |
| Total Equity | -2.18M | -235k | 933k | 2.01M | 4.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.42M | -4.15M | -3.94M | -2.76M | -2.37M |
| Investing | -35k | -123k | -34k | -271k | -478k |
| Financing | 4.47M | 4.34M | 4.23M | 3.96M | 4.66M |
| Market Cap | 98.82M |
| Price to Earnings Ratio | -28.10 |
| Price to Sales Ratio | 8.06 |
| Price to Cash Ratio | 27.87 |
| Price to Book Ratio | 23.42 |
| Dividend Yield | - |
| Shares Outstanding | 289.5M |
| Average Volume (1 week) | 134.07k |
| Average Volume (1 Month) | 185.14k |
| 52 Week Change | 79.75% |
| 52 Week High | 0.4499 |
| 52 Week Low | 0.15 |
| Spread (Intraday) | 0.01 (3.84%) |
| Company Name | BioLargo Inc (QB) |
| Address |
one commerce center wilmington, massachusetts 19801 |
| Website | https://www.biolargo.com |
| Industry | chemicals & allied products (2800) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
